All rights reserved to the presidency Copyright © 2020
Gypto Pharma is one of the most important national projects the state implemented with the aim of possessing the modern technological and industrial capacity in this vital field. This project, in turn, would help citizens obtain high-quality and safe pharmacological treatment, end monopolistic practices, and control the prices of medicines.
In fact, this mega project supports the efforts made by the State concerning medical and health initiatives and services provided for citizens.
Gypto Pharma is one of the largest medicine cities in the Middle East. It covers an area of 180,000 square meters. It is equipped with the latest technologies and global systems in pharmaceutical production to become a regional hub that attracts major international companies in the field of pharmaceutical and vaccine industries.
Description:
Established in two phases, the project covers an area of 180,000 square meters.
• The current phase covers an area of 120,000 square meters:
It includes buildings for traditional medicine production, administration, industrial services, and networks.
• The future phase covers an area of 60,000 square meters:
It includes factories producing biosimilars, oncology medications, β-Lactam antibiotics, hormone drugs, and vaccines.
The traditional medicine-related premises includes:
• Factory for solid preparations:
It includes production lines for tablets, capsules, sachets, and effervescent and powder formulations.
• Factory for semi-solid preparations:
It includes production lines for ointments, creams, suppositories, and gelatin capsules.
• Factory for liquid preparations:
It includes production lines for syrups and oral drops.
• Factory for sterile preparations:
It includes production lines for ophthalmic drops, dental anesthetics, ampoules, and intravenous (IV) fluids.
Project Goals:
1- Providing effective, safe and high-quality pharmacological treatment.
2- Achieving medical security and putting an end to monopolistic practices.
3- Establishing a regional hub for pharmaceutical industry to attract international companies.
4- Exporting.
5- Localizing the pharmaceutical industry.
Gypto Pharma is one of the most important national projects the state implemented with the aim of possessing the modern technological and industrial capacity in this vital field. This project, in turn, would help citizens obtain high-quality and safe pharmacological treatment, end monopolistic practices, and control the prices of medicines.
In fact, this mega project supports the efforts made by the State concerning medical and health initiatives and services provided for citizens.
Gypto Pharma is one of the largest medicine cities in the Middle East. It covers an area of 180,000 square meters. It is equipped with the latest technologies and global systems in pharmaceutical production to become a regional hub that attracts major international companies in the field of pharmaceutical and vaccine industries.
Description:
Established in two phases, the project covers an area of 180,000 square meters.
• The current phase covers an area of 120,000 square meters:
It includes buildings for traditional medicine production, administration, industrial services, and networks.
• The future phase covers an area of 60,000 square meters:
It includes factories producing biosimilars, oncology medications, β-Lactam antibiotics, hormone drugs, and vaccines.
The traditional medicine-related premises includes:
• Factory for solid preparations:
It includes production lines for tablets, capsules, sachets, and effervescent and powder formulations.
• Factory for semi-solid preparations:
It includes production lines for ointments, creams, suppositories, and gelatin capsules.
• Factory for liquid preparations:
It includes production lines for syrups and oral drops.
• Factory for sterile preparations:
It includes production lines for ophthalmic drops, dental anesthetics, ampoules, and intravenous (IV) fluids.
Project Goals:
1- Providing effective, safe and high-quality pharmacological treatment.
2- Achieving medical security and putting an end to monopolistic practices.
3- Establishing a regional hub for pharmaceutical industry to attract international companies.
4- Exporting.
5- Localizing the pharmaceutical industry.
All rights reserved to the presidency Copyright © 2020
All rights reserved to the presidency Copyright © 2020